The immune checkpoint inhibitor immunotherapy of tumor mainly refers to a new treatment method of using PD-1 and CTLA4 inhibitors to enhance the immune function of the body by increasing the antitumor activity of T cells and achieve the purpose of eliminating the tumor (8). The gene discussed is PDCD1; the disease is neoplasm.